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PURPOSE: To compare the effectiveness of pelvic floor exercises, electrical stimulation, vaginal cones, and no active treatment 
in women with urodynamic stress urinary incontinence. 
PATIENTS AND METHODS: One hundred eighteen subjects were randomly selected to recieve pelvic floor exercises (n=31), 
ES (n=30), vaginal cones (n=27), or no treatment (untreated control) (n=30). Women were evaluated before and after completion 
of six months of treatment by the pad test, quality of life questionnaire (I-QOL), urodynamic test, voiding diary, and subjective 
response. 
RESULTS: In the objective evaluation, we observed a statistically significant reduction in the pad test (p=0.003), in the number of 
stress urinary episodes (p<0.001), and a significant improvement in the quality of life (p<0.001) in subjects who used pelvic floor 
exercises, electrical stimulation, and vaginal cones compared to the control group. No significant difference was found between 
groups in the urodynamic parameters. In the subjective evaluation, 58%, 55%, and 54% of women who had used pelvic floor ex-
ercises, electrical stimulation, and vaginal cones, respectively, reported being satisfied after treatment. In the control group, only 
21% patients were satisfied with the treatment. 
CONCLUSION: Based on this study, pelvic floor exercises, electrical stimulation, and vaginal cones are equally effective treat-
ments and are far superior to no treatment in women with urodynamic stress urinary incontinence.
KEYWORDS: Stress urinary incontinence. Electrical stimulation. Pelvic floor exercise. Vaginal cones. Urodynamic.
INTRODUCTION
Urinary incontinence is generally defined as the 
involuntary loss of urine. It produces serious economic, 
social, and psychological problems that have a significant 
impact on women’s health.1 Its prevalence ranges from 3% 
to 55% depending on the definition of incontinence used 
and the age of the population studied.2 Urinary incontinence 
affects approximately 29.5 million Americans and costs an 
estimated 26.4 billion dollars annually in the United States 
(US).3,4
Stress urinary incontinence (SUI) is involuntary 
leakage of urine during effort, exertion, sneezing, 
or coughing.1 It is the most common type of urinary 
incontinence in women, and 1/3 of women present with 
symptoms of SUI in a pure or mixed form.3 In 1997, 
this disease was treated with fewer than 130,000 anti-
incontinence procedures in the US.5 
Several conservative treatment options are avaiable for 
the management of SUI, e.g., physical therapies, behavioral 
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modification, and pharmacological intervention.3 Physical 
therapies involving pelvic floor muscle training with or 
without other treatments such as vaginal cones, biofeedback, 
and electrical stimulation are the standard for conservative 
treatment and prevention of SUI.6 However, few studies 
have directly compared the clinical efficacy and urodynamic 
outcomes of the different treatment options.6,7
According to a review by Cochrane, pelvic floor muscle 
training must be included in the first-line of conservative 
management programs for women with SUI, but randomized 
controlled trials evaluating the use of electrical stimulation 
and vaginal cones have provided inconclusive results.7 To 
assess if there is a difference between each of the modalities 
pelvic floor muscle training versus electrical stimulation 
versus vaginal cones, and to determine if one or more 
are effective than no active treatment, we conducted a 
randomized, single-blinded, controlled trial comparing these 
physical therapies in the management of women with stress 
urinary incontinence. 
PATIENTS AND METHOD
Women with proven urodynamic stress urinary 
incontinence were successively enrolled in this single-
blinded, controlled, randomized trial at the Urogynecology 
and Reconstructive Pelvic Surgery, a division of the 
Gynecology Department at the Federal University of São 
Paulo.
Subjects were required to have urodynamic stress 
incontinence and no detrusor overactivity, a positive 
cough stress test, and > 3g leakage measured by a pad 
test with a standardized bladder volume (200ml).8 All 
subjects had symptoms of SUI with an average of at 
least 3 stress incontinence episodes a week. Additional 
major exclusion factors included patients with chronic 
degenerative diseases that would affect muscular and nerve 
tissues, advanced genital prolapses, pregnancy, active or 
recurrent urinary tract infections, vulvovaginitis, atrophic 
vaginitis, continence surgery within one year, and patients 
with cardiac pacemakers. We also excluded patients with 
intrinsic sphincteric deficiencies identified by the Valsalva 
leak point pressure ≤ 60cm H20 measurement in the sitting 
position with a volume of 250 ml in the bladder and/or by 
the measurement of a urethral closure pressure ≤20cm H20 
in the sitting position at maximum cystometric capacity. 
The study was approved by the Institutional Review Board 
Committe from the Federal University of São Paulo. Each 
participant signed a written consent. The power calculation 
of the study was based on the power estimate and results 
of a previous study designed to detect differences between 
groups of 1SD, with a 0.05 significance level and power 
of 0.8. In the previous study, significant differences in the 
same outcomes were shown in groups of 23 and 31 subjects; 
therefore, 30 participants were recruited for each of the four 
groups in this trial.9-14
Once enrolled by a physician investigator, subjects were 
assigned to four distinct groups: pelvic floor exercises, 
electrical stimulation, vaginal cones, or untreated controls. 
The division of the four groups was undertaken by using 
computer-generated random numbers prepared by the 
Biostatistics Center of the Federal University of São Paulo. 
The investigator responsible for assessing patients outcomes 
(RAC) was not involved in administering any of the 
treaments and was blind to the group assignments.
Outcome mesures 
At the initial visit, all subjects underwent a complete 
medical history and physical examination including a pad 
test with a standardized bladder volume (200 ml),8 a voiding 
diary recording the number of incontinence episodes during 
7 days, and vaginal muscle strength assessment using the 
Oxford grading system. A urodynamic evaluation was also 
performed. Methods, definitions, and units conformed to 
standards proposed by the International Continence Society.1 
All study subjects were also asked to complete the validated 
Incontinence Quality of Life Questionnaire (I-QoL)15 
containing one section. A score of 100 represented the best 
possible quality life, and 0 represented the worst possible 
quality of life.15
The primary outcome measurement was the objective 
cure of stress incontinence based on a negative pad test with 
a standardized bladder volume8 (<2g in weight). Secondary 
outcome measures included changes in the validated quality 
of life questionnaire (I-QoL),9 the number of leakages in the 
voiding diary, and the urodynamic test. A subjective curing 
of SUI was measured by a simple question as to how the 
patient felt about her incontinence problem after treatment. 
The only two answer options available were “satisfied” 
and “dissatisfied”. Answering “satisfied” indicated that 
the patient did not want a different treatment. Answering 
“dissatisfied” indicated that the patient wanted a treatment 
different than the initial one. 
Interventions
Qualified instructors provided subjects with explanations 
about the anatomy of the pelvic floor muscle and lower 
urinary tract, physiology, and continence mechanisms. All 
subjects were taught to contract the pelvic floor muscles 
correctly, and this was assessed by vaginal palpation. In the 
active group, the subjects were told that the three treatments 
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were expected to be equally effective during a six-month 
trial period.
Pelvic Floor Muscle Training group
Once proper contractions were confirmed, the pelvic 
floor muscle training began. The sequence of contractions 
of the pelvic floor was as follows: 10 repetitions of 
5-second contractions with 5 seconds of recovery time; 
20 repetitions of 2-second contractions with 2 seconds of 
recovery; 20 repetitions of 1-second contractions with 1 
second of recovery; 5 repetitions of 10-second contractions 
with 10 seconds of recovery followed by 5 repetitions of 
strong contractions together with stimulated cough with a 
1-minute interval between sets. All the sessions were held 
in groups for 45 minutes. At the beginning of each session, 
general warm-up exercises of the joints were performed, 
and stretching exercises of the hips, adductors, hamstrings, 
and paravertebral muscles were performed at the end of 
the session.
Electrical stimulation group
The electrodes used for the transvaginal electrical 
stimulation (ES) were cylindrical and approximately 10 
cm long and 3.5 cm wide, with a double metal ring. The 
electrodes were inserted into the middle third of the vagina, 
close to the sciatic spine and next to the pudendal nerve, 
at the level of the pubococcygeal muscle. The electrical 
parameters selected were a 50Hz frequency, 5-second-on and 
10-second-off cycle, and a pulse width of 0.5 milliseconds. 
The bipolar square wave could be delivered over a range that 
varied from 0 to 100mA, depending on the maximum current 
intensity comfortably tolerated by the patient. Each treatment 
was given for 20 minutes.
Vaginal cones group 
Subjects treated with the weighted vaginal cones received 
nine cones of equal shape and volume, increasing in weight 
from 20 to 100g. Starting with the lightest weight, women 
were taught to place the cone into the vagina while standing. 
The heaviest weight that could be retained in place for one 
minute without voluntarily contracting the pelvic floor was 
called the passive cone. The patient would then use the 
next heavier weight that required a voluntary contraction 
of the pelvic floor to prevent the cone from slipping out of 
the vagina. The heaviest weight that could be retained with 
muscular contraction was the active cone. Women were 
instructed to do the exercises with cones for 45 minutes. 
For all three intervention groups, sessions were 
performed at our urogynecology unit three times a week 
with the supervision of a trained physical therapist. The 
subjects in the untreated control group had no contact with 
the therapist during the trial, but they received a motivational 
phone call once a month during the intervention period. 
Adverse events and compliance with all treatments were 
recorded in a training diary updated by the physical therapist 
in charge of the sessions during each clinic visit.
Statistical analysis
We analyzed the data only for those women who 
completed the study. Data were entered using Excel 
software and analyzed by SAS 8.1 (SAS Institute, Cary, 
North Carolina). P<0.05 was considered statistically 
significant. The data are presented as mean ± SD, with 
the range in parentheses, or frequency. For the continuous 
variables of interest, the Kruscal-Wallis test was used 
to compare the differences among the four groups and 
was followed by the Mann-Whitney U test if the overall 
difference was statistically significant. In the Mann-
Whitney U test, the significance level was adjusted to 
0.008 by the number of comparisons. The chi-square 
test was used to examine the differences in categorical 
characteristics among groups. 
RESULTS
A total of 118 women were randomized into four 
groups, 17 (14%) of whom withdrew from the study, 
leaving a total of 101 subjects who completed the trial. 
Nine (7.6%) of the women abandoned the study for lack 
of clinical improvement less than six weeks of treatment: 
two belonged to the pelvic floor muscle training group, 
one from the electrical stimulation group, four from the 
vaginal cone group, and two from the untreated group. 
Eight (6.4%) of the women withdrew their consent and 
could not complete the study (change of city, family 
problems, pregnancy): one from the pelvic floor muscle 
training group (pregnancy), two from the electrical 
stimulation group (family problem, pregnancy), two from 
the vaginal cone group (family problems, change of city), 
and three women from the untreated group (change of 
city) (Figure 1). This left 26 women in the pelvic floor 
muscle training, 27 in the electrical stimulation group, 24 
in the vaginal cones group, and 24 in the untreated group 
(Figure 1).
At baseline, there were no significant differences between 
the groups in any of demographics, clinical characteristics, 
or outcome measurements such as age, BMI, pregnancy, 
parity, hormonal status, duration of symptoms, vaginal 
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deliveries, number of C-sections, hysterectomy, previous 
surgery for stress urinary incontinence, pad test, I-QOL 
questionaire, voiding diary, muscle strength, and urodynamic 
parameters. The race variable proved statistically different 
among the groups analyzed; i.e., groups that carried out 
eletrical stimulation and vaginal cones were composed of 
predominantly white women compared to the pelvic floor 
muscle training and untreated groups (Tables 1,2,3).
Subject compliance was acceptable, with a mean 
compliance of 92% in the pelvic floor muscle training group, 
91% in the electrical stimulation group, and 93% in the 
vaginal cones group after six months of treatment.
Figure 1- Flow of participants through trial
Table 1 - Baseline demographic and clinical characteristics by treatment group
Variables PFMT
n=26
ES
n=27
Cones
n=24
Control
n=24
P value*
Race White 12 (57.1) 14 (60.9) 20 (95.2) 18 (75.0) 0.024
Non-White 9 (42.9) 9 (39.1) 1 (4.8) 6 (25.0)
Age 56.2 ± 12.5 55.2 ± 12.8 52.6 ± 11.2 52.6 ± 11.2 0.788
BMI 25.9 ± 5.0 21.9±3.9 24.1±4.6 26.9 ± 5.1 0.180
Durations of Symptoms 4.9 ± 3.0 5.0 ± 3.9 3.2 ± 2.1 6.0 ± 4.9 0.236
Pregnancy 3.9 ± 2.3 5.1 ± 3.2 4.2 ± 2.5 4.8 ± 3.0 0.644
Vaginal delivery 2.8 ± 1.9 3.5 ± 2.6 3.0 ± 2.1 3.1 ± 2.7 0.896
C-section delivery 0.5 ± 0.9 0.7 ± 0.9 0.6 ± 0.8 0.8 ± 1.0 0.489
No (%) menopausal 11 (47.8) 11 (45.8) 10 (47.6) 9 (42.9) 0.987
No (%) hormone replacement therapy 3 (33) 3 (27) 3 (30) 3 (27) 0.925
No (%)hysterectomy 3 (13) 4 (16) 3 (14) 3 (14) 0.890
No (%) Previous incontinence surgery 4 (17) 7 (29) 4 (20) 4 (19) 0.762
‡ Data presented as mean ± SD, data in parenthesis are percentages; * Denotes overall comparison among four groups using Kruskal -Wallis test or chi-
square test
469
CLINICS 2008;64:465-72 Single-blind, randomized, controlled trial of pelvic floor muscle training
Castro RA et al.
Primary outcome measurement
A negative pad test with a standardized bladder volume 
was observed in 12 (46%) subjects in the pelvic floor PFMT 
group, 13 (48%) in the ES group, 11 (46%) in the vaginal 
cone group, and only 2 (8.0%) in the untreated control group, 
respectively. There was a significant decrease in the pad 
weight in all groups, but, when the analysis was carried out 
among the groups, we noted that patients who used active 
treatment showed a significant decrease in pad weight when 
compared to the control group (p=0.003) (Table 2). There 
was no significant difference of these measurements between 
the three physical therapy techniques after six months of 
treatment (Table 3).
Secondary outcome measurements
Results of the I-QoL Questionnaire are shown in Table 
2. After six months, the active subject group showed 
a significant change in the quality of life compared to 
untreated controls (p=0.002). The quality of life increased 
significantly in 28.4% of the PFMT group, 32.4% of the ES 
group, and 30.3% of the vaginal cones group. There was no 
modification in the untreated group (-3.6%) (Table 2). When 
we compared the active groups, no significant difference was 
identified between them (Table 3). 
Analyzing the voiding diariy, the phisical therapy 
techniques had a significantly greater impact in decreasing 
the stress incontinence episodes compared with the 
control group (p<0.001) (Table 2). There was no significant 
difference between the treatment groups (Table 3).
Changes in urodynamic parameters are summarized in 
Table 4. Stress testing for urodynamic stress incontinence 
was negative at the cystometry in 10 (38%), 11 (41%), 9 
(37%), and 3 (12%) of the subjects in the PFMT, ES, vaginal 
cones, and untreated control groups, respectively. Initial 
bladder capacities and maximum sensation and residual urine 
were normal in all subjects and did not change significantly 
after treatment. Average and maximum flow rates in 
fluxometry were within a normal range in all subjects before 
and after treatment. Maximun urethral closure pressure or 
functional profile length on urethral pressure profile did not 
Table 2 - Outcome measure and muscle strengh at baseline and 6 months divided by treatment group
Variables PFMT
n=26
ES
n=27
Cones
n=24
Control
n=24
P value*
IQoL questionaire(%)( baseline) 56.4 (19.0) 55.5 (17.8) 55.5 (22.3) 61.1 (22.8) 0.282
IQoL questionaire(%) (6 months) 82.2 (17.6) 83.4 (12.1) 82.7 (14.2) 57.6 (28.2) 0.002**
IQoL questionaire(%) (6 months-baseline) 25.7(15.4) 27.8 (19.9) 27.2 (23.2) - 3.6 (14.0) < 0.001**
PAD Test volume (200 ml) (baseline) 39.7 (25.4) 37.0 (28.0) 36.6 (20.4) 37.9 (24.1) 0.326
PAD Test volume (200 ml) (6 months) 8.4 (15.8) 9.1 (14.6) 8.0 (12.6) 21.0 (18.5) 0.003**
No (%) with weight< 2g (6 month) 12 (46) 13 (48) 11 (46) 3 (8)
Voiding dairy 7days / leakages (baseline) 10.3 (10.1) 12.7 (12.0) 12.6 (4.4) 10.5 (7.0) 0.710
Voiding dairy 7days / leakages (6 months) 2.7 (3.6) 2.3`(5.5) 1.5 (1.8) 8.8 (6.3) < 0.001**
Muscle strengh oxford scale (baseline) 2.1 (0.8) 2.0 (0.8) 2.0 (0.6) 2.1 (0.8) 0.918
Muscle strengh oxford scale (6 months) 3.6 (0.71) 2.9 (1.00) 3.0 (0.89) 2.3(1.07) 0.002***
Subjective response Satisfied No(%) (6 months) 15 (58) 15 (55) 13 (54) 5 (21)
Subjective response Dissatisfied No(%) (6 months) 11 (42) 12 (45) 11(46) 19 (79)
‡ Data presented as mean(SD); * Denotes overall comparison among four groups using Kruskal -Wallis test or pairwise test using the Mann-Whittney U 
test; ** 6 months PFMT = ES= Cones ≠ Control; *** 6 months PFMT ≠ ES= Cones = Control
Table 3 - Outcome measure and multiple comparison of all groups at 6 months
Variaables PFMT v Control ES v Control Cones v Control PFMT v ES PFMT v  Cones ES v Cones
IQoL questionaire(%) < 0.001* < 0.001* < 0.001* 0.777 0.653 0.343
PAD Test volume (200 ml) 0.001* 0.001* 0.002* 0.312 0.432 0.143
Voiding dairy 7days / leakages < 0.001* < 0.001* < 0.001* 0.657 0.786 0.065
Muscle strengh oxford scale 0.001* 0.06 0.07 0.002* 0.001* 0.121
Mann-Whittney U tes; *Significant difference, p<0.008
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change after treatment in either treatment group. 
Subjectively, 15 (58%), 15 (55%), 13 (54%), and 5 (21%) 
of the women in the pelvic floor muscle training, electrical 
stimulation, vaginal cone, and untreated control groups, 
respectively, claimed to be satisfied and did not desire a 
different treatment after the six month study treatment period 
(Table 2). 
Muscle strength
There was no significant improvement in the muscle 
strength as measured by the Oxford scale in the untreated 
control group, but significant improvement was seen after six 
months of treament in the active groups. The improvement 
in the strength of the pelvic floor muscle was significantly 
greater in the PFMT group compared with the electrical 
stimulation and the vaginal cones groups (p=0.002) (Table 
2). There was no significant difference in the muscle strength 
between electrical stimulation, vaginal cones, and untreated 
control groups (Table 3).
DISCUSSION
Urinary incontinence is a common health problen among 
women and is associated with a poor self-rated health, 
impairment in quality of life, social isolation, and symptoms 
of depression1 It has a complex pathophysiology, which 
calls for diferent therapeutic techniques depending on the 
mechanism involved in the origin of urine loss.16,17 
The concept that neurologic and muscular injury of 
the pelvic floor causes genital prolapse and stress urinary 
incontinence has been proposed by several researchers.18-20 
Because the pudendal nerve is an efferent nerve for both 
the pelvic floor muscle and the external urethral sphincter, 
its damage can generate both weakness of the pelvic floor, 
resulting in pelvic organ prolapsed, and relaxation of 
the external urethral sphincter, resulting in stress urinary 
incontinence.21 Thus, neuromuscular damage plays a 
fundamental role in maintaining continence and integrity of 
the pelvic floor. 
Based on neuromuscular lesions, several treatments have 
arisen with the objective of reestablishing the function of 
muscles and nerves that make up the pelvic floor. Physical 
therapy techniques are capable of treating this disease, 
improving the muscle and nerve components of the pelvic 
organ support system.17
 The treatment of stress urinary incontinence by 
pelvic floor muscle training, vaginal cones, and pelvic 
floor electrostimulation presents conflicting results. The 
difficulty in interpreting the literature may be seen in the 
meta-analysis carried out by Hay-Smith et al. (2007), who, 
despite having selected 43 randomized clinical studies, 
Table 4 - Urodynamic data at baseline and 6 months after treatment
Cystometry PFMT
n= 26
ES
n=27
Cones
n=24
Control
n=24
P value*
Volume at first desire to void (ml) baseline 133.7 ± 51.4 138.9 ± 61.4 129.3 ± 50.6 135.5 ± 61.2 0.929
Volume at first desire to void (ml) 6 months 141.3 ± 46.6 147.9 ± 75.9 139.3 ± 53.2 136.2 ± 47.7 0.09
Maximun cystometric capacity (ml) baseline 515.4 ± 131.9 531.1 ± 157.4 533.8 ± 157.8 520.9 ± 154.1 0.823
Maximun cystometric capacity (ml) 6 months 545.4 ± 123.8 579.3 ± 142.6 535.7 ± 109.8 473.8 ± 107.9 0.236
Post micturation residual (ml) baseline 1.4 ± 3.5 7.9 ± 20.4 4.6 ± 10.0 2.6 ± 10.9 0.880
Post micturation residual (ml) 6 months 1.7 ± 3.6 7.5 ± 15.0 2.2 ± 3.7 7.8 ± 17.1 0.707
No (%) with negative stress test (urodynamic) 6 months 10(38) 11(41) 9(37) 3(12)
Urethral pressure profile
Functional urethral lengh (cm) baseline 2.5 ± 0.8 3.1 ± 3.9 2.7 ± 0.8 2.4 ± 0.9 0.528
Functional urethral lengh (cm) 6 months 2.6 ± 0.8 2.5 ± 0.7 2.6 ± 0.7 2.3 ± 0.7 0.460
Maximum urethral closure pressure(cm) baseline 53.5 ± 16.5 52.2 ± 18.9 58.4 ± 19.8 61.2 ± 28.1 0.519
Maximum urethral closure pressure(cm) 6 months 53.4 ± 13.0 51.9 ± 16.8 56.9 ± 16.0 53.8 ± 14.9 0.518
Fluxometry
Maximum flow rate ml/s baseline 25.8 ± 9.2 30.4 ± 9.7 29.2 ± 10.8 25.8 ± 8.3 0.614
Maximum flow rate ml/s 6 months 26.5 ± 8.1 29.3 ± 11.3 24.5 ± 10.9 27.4 ± 8.1 0.125
Avarage flow rate ml/s baseline 14.3 ±6.9 14.1 ± 6.4 17.5 ± 9.3 15.4 ± 7.5 0.909
Avarage flow rate ml/s 6 months 15.1 ± 5.6 16.9 ± 7.1 15.9 ± 4.7 16.7 ± 5.8 0.445
‡ Data presented as mean ± SD, data in parenthesis are percentages; * Denotes overall comparison among four groups using Kruskal -Wallis test
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exercises, electrical stimulation, and vaginal cones.
The improvement in the strength of pelvic floor muscles 
was significantly greater in the PFMT group compared 
with electrical stimulation and vaginal cones. Our study 
has insufficient statistical power to observe any differences 
in the muscle strength between electrical stimulation 
treatment, vaginal cone treatment, and untreated controls 
(Table 3). 
We did not observe any significant changes in regards 
to the urodynamic evaluation for most of the variables 
studied, including maximun urethral closure pressure, which 
could justify treatment success. However, it is important to 
remember that the correlation between clinical improvement 
and urodynamic changes remains controversial. 
This study did not reproduce the data generated by 
Bo et al. (1999), in which pelvic floor muscle training 
was more effective than electrical stimulation, vaginal 
cones, and no treatment control for women with stress 
urinary incontinence. This discrepancy in results may 
be due to differences in how the two studies carried out 
active treatment. In the present study, a physiotherapist 
supervised all sessions, coordinated the pelvic floor 
exercises, increased the intensity of electrical impulses, 
and encouraged the use of vaginal cones. This engagement 
was probably responsible for the high compliance with 
active treatment and the favorable treatment outcomes 
based on subjective and objective measures, especially in 
the electrical stimulation and vaginal cone groups.
Despite the fact that all active groups were equally 
effective, pelvic floor muscle training must still be the 
first-line of conservative management programs for women 
with SUI. Electrical stimulation and vaginal cones should 
be offered to patients who cannot contract their pelvic 
floor muscle. Several studies have demonstrated that more 
than 30% of incontinent women are unable to contract 
their pelvic floor muscle correctly.23
We share the opinion that the therapeutic success of 
the physical therapy techniques depends on the degree of 
motivation of the woman. For this reason, we consider the 
association of an education program extremely important 
so that subjects can understand their disease and choose the 
best treatment.
In conclusion, this study provides evidence that pelvic 
floor muscle training, electrical stimulation, and vaginal 
cones are equally effective and better than no treament in 
the management of women with urodynamic stress urinary 
incontinence. Also, our study supports the idea that pelvic 
floor muscle exercise should be offered as the first choice 
of treatment.
concluded that larger clinical trials with more concise 
methods were still needed. Statistical heterogeneity 
reflecting variations in incontinence type, training, and 
different outcome measurements are the problems that have 
made interpretation most difficult.
The high cost of this disorder, presently around 26 
billion dollars in the US, as well as its high prevalence,2-4 
raises this disease to the position of one of the most 
serious public health problems in the world, particularly 
in developing countries such as Brazil. 
We analyzed and compared the effectiveness of pelvic 
floor muscle training, electrical stimulation, vaginal cones, 
and untreated control. Evaluating our results, we concluded 
that pelvic floor muscle training, electrical stimulation, 
and vaginal cones are effective in treating women with 
stress urinary incontinence. We observed a significant 
improvement in all outcome measures. The subjective rate 
of success of those physical therapies was approximately 
56%, and the objective (pad test) rate was approximately 
47%. Treatment was very well tolerated, and no adverse 
events, such as vaginal bleeding, urinary infection, and 
vulvovaginitis, could be correlated with any of the active 
treatments. 
The most appropriate outcome measure for lower urinary 
tract symptoms is still undetermined. In a subjective analysis, 
Lagro-Janssen et al. (1991) observed a rate of 85% of cure 
and improvement after pelvic floor muscle training, although 
the authors point out that only 21% of the patients felt 
completely dry after treatment. The difficulty in analyzing 
this study lies in determining the true clinical behavior of the 
patients who improved after using pelvic floor exercises. 
We attempted to use both objective and subjective 
outcome parameters in this study. A pad test with a 
standardized bladder volume was chosen as the primary 
outcome measure because it has been used in most clinical 
trials. In the the subjective analysis, we tried to reach 
what we understand is the “cure” to this condition.22 The 
satisfaction of our patients meant that no other treatment, 
including a surgical procedure, was required. The nine 
women who abandoned the study for lack of clinical 
improvement underwent a tension-free vaginal tape 
procedure.
The significant improvements in quality of life that 
were demonstrated in this trial are important because 
they help us to understand the clinical relevance in the 
alterations in the pad test and voiding diary. The significant 
reduction in the number of stress urinary episodes and pad 
weight is responsible for more than a 30% increase in the 
quality of life in subjects who were treated using pelvic floor 
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